Overview

Health Assessment Study (0954-946)

Status:
Completed

Trial end date:
2003-01-23

Target enrollment:

Participant gender:

Summary

The study will look at the effects of losartan or atenolol on frequency of sexual intercourse in subjects with newly diagnosed mild to moderate hypertension.

Phase:

Phase 3

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Atenolol